According to Coherent Market Insights, the global degenerative disc disease treatment market was valued at US$ 1,736.4 million in 2019 and is expected to exhibit a CAGR of 9.0% over the forecast ...

Findings from an interim analysis showed CELZ-201-DDT statistically significantly reduced pain and improved mobility in patients with chronic lower back pain. The Food and Drug Administration (FDA) ...

Degenerative disc disease (DDD) and intervertebral disc degeneration (IVDD) represent conditions that impair the function of the spinal motion segments, profoundly affecting quality of life worldwide.

FibroBiologics is pursuing a development program for FSdC spheroids with the goal of advancing to clinical trials. The data includes comprehensive preclinical pharmacology and efficacy assessments ...

BackFit Health + Spine provides comprehensive pain management services at its South Chandler location, responding to the ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

NEW HAVEN, Conn. (WTNH) — In today’s Health Headlines, what is degenerative joint disease? New research has revealed how these diseases actually happen and what new treatments are on the horizon as a ...

FibroBiologics (FBLG) announced preclinical results for FSdC, an investigational FSdC spheroid-based therapy, demonstrating superior improvement ...

Older adults, particularly those with a history of stooped or physically demanding work, are at higher risk for developing LDK. Lumbar degenerative kyphosis (LDK) is a spinal condition often seen in ...